Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Inmode Ltd.
InMode to Present at Upcoming Investor Conferences Before the End of 2022
Business
Nov 1 2022
4 min read

InMode to Present at Upcoming Investor Conferences Before the End of 2022

YOKNEAM, Israel, Nov. 1, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that InMode will present at the following investor conferences in November:

InMode Logo

13th Annual Jefferies London Healthcare Conference Presenters: Moshe Mizrahy, Chairman and Chief Executive Officer and Adrian Myrick, VP, Europe & Middle EastFormat: In-person presentation and one-on-one meetingsLocation: London, U.K.When: Presentation scheduled for 10:20 a.m. GMT on Tuesday, November 15A live webcast of the presentation can be accessed here.

2022 Canaccord Genuity MTDF ConferencePresenters: Moshe Mizrahy, Chairman and Chief Executive Officer, Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical OfficerFormat: In-person presentation and one-on-one meetingsLocation: NYC, U.S.When: Presentation scheduled for 1:00 pm ET on Thursday, November 17A live webcast of the presentation can be accessed here.

Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference Presenters: Yair Malca, Chief Financial Officer and Spero Theodorou MD, Chief Medical OfficerFormat: In-person panel discussion and one-on-one meetingsLocation: Miami Beach, U.S.When: Panel scheduled for 1:45 pm ET on Thursday, December 8

About InMode InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Investor Relations Contact:     Miri Segal-SchariaMS-IR LLCir@inmodemd.com 917-607-8654 

Cision View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-upcoming-investor-conferences-before-the-end-of-2022-301663690.html

SOURCE InMode Ltd.